These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3160753)

  • 21. Cortisol nonsuppression in depression: relationship to clinical variables.
    Roy A
    J Affect Disord; 1988; 14(3):265-70. PubMed ID: 2968388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.
    Beeber AR; Kline MD; Pies RW; Manring JM
    J Nerv Ment Dis; 1984 May; 172(5):301-3. PubMed ID: 6716096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test and DSM-III-R diagnoses in suicide attempters.
    Westrin A; Frii K; Träskman-Bendz L
    Eur Psychiatry; 2003 Nov; 18(7):350-5. PubMed ID: 14643563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The implications of DSM-III personality disorders for patients with major depression.
    Pfohl B; Stangl D; Zimmerman M
    J Affect Disord; 1984 Dec; 7(3-4):309-18. PubMed ID: 6241212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic validity of self-report and interview measures of personality disorder in depressed inpatients.
    Pfohl B; Coryell W; Zimmerman M; Stangl D
    J Clin Psychiatry; 1987 Dec; 48(12):468-72. PubMed ID: 3693330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation between the MMPI profiles and the results of the dexamethasone suppression test in patients with major depression].
    Conde López V; Cuesta Zorita MJ; Fernández Abeijon MD
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(5):351-61. PubMed ID: 3799263
    [No Abstract]   [Full Text] [Related]  

  • 27. Major depression in the elderly: DSM-III criteria and the dexamethasone suppression test as predictors of treatment response.
    Spar JE; La Rue A
    Am J Psychiatry; 1983 Jul; 140(7):844-7. PubMed ID: 6859297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An elaborate description of the symptomatology of patients with Research Diagnostic Criteria endogenous depression.
    de Jonghe F; Ameling E; Assies J
    J Nerv Ment Dis; 1988 Aug; 176(8):475-9. PubMed ID: 3404139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of the MMPI-2 in conjunction with the NEO-Personality Inventory.
    Stein MB; Hackerman FR
    Psychol Rep; 1991 Dec; 69(3 Pt 1):955-8. PubMed ID: 1784691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
    Lahmeyer HW; Val E; Gaviria FM; Prasad RB; Pandey GN; Rodgers P; Weiler MA; Altman EG
    Psychiatry Res; 1988 Jul; 25(1):19-30. PubMed ID: 3217463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of MCMI DSM-III axis II constructs from MMPI scales and subscales.
    Zarrella KL; Schuerger JM; Ritz GH
    J Pers Assess; 1990; 55(1-2):195-201. PubMed ID: 2231239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of MMPI patterns in patients with psychogenic pseudoseizures.
    Kalogjera-Sackellares D; Sackellares JC
    Seizure; 1997 Dec; 6(6):419-27. PubMed ID: 9530936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the depressive border of the borderline personality disorder.
    Snyder S; Sajadi C; Pitts WM; Goodpaster WA
    Am J Psychiatry; 1982 Jun; 139(6):814-7. PubMed ID: 7081498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of DSM-5 section II personality disorder constructs using the MMPI-2-RF in clinical and forensic samples.
    Anderson JL; Sellbom M; Pymont C; Smid W; De Saeger H; Kamphuis JH
    Psychol Assess; 2015 Sep; 27(3):786-800. PubMed ID: 25799092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of psychopathology, personality, and marital interaction on the short-term course of major depression.
    Mundt C; Kronmüller KT; Backenstrass M; Reck C; Fiedler P
    Psychopathology; 1998; 31(1):29-36. PubMed ID: 9500684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMPI personality disorder scales and the MCMI: concurrent validity.
    McCann JT
    J Clin Psychol; 1989 May; 45(3):365-9. PubMed ID: 2745725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result.
    O'Flynn K; Dinan TG
    Am J Psychiatry; 1993 Nov; 150(11):1728-30. PubMed ID: 8214184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J; Lipper S; Zung WW; Strickland R; Krishnan R; Mahorney S
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.